| Recent advances in HER2-targeted delivery for cancer therapy RK Dhritlahre, A Saneja Drug Discovery Today 26 (5), 1319-1329, 2021 | 35 | 2021 |
| Recent advances in dual-ligand targeted nanocarriers for cancer therapy N Khan, RK Dhritlahre, A Saneja Drug Discovery Today 27 (8), 2288-2299, 2022 | 14 | 2022 |
| Self-emulsifying formulations to augment therapeutic efficacy of nutraceuticals: From concepts to clinic RK Dhritlahre, Y Padwad, A Saneja Trends in Food Science & Technology 115, 347-365, 2021 | 13 | 2021 |
| Formononetin-Vitamin E Conjugate Synergistically Supports Adipogenesis, Attenuates Oxidative Stress, and Restores Insulin Sensitization in Differentiated Preadipocytes AS R. K. Dhritlahre, A. Goel, R. Rana, S. K. Maurya, Y. Padwad ChemistrySelect, ISSN:2365-6549 9 (1), e202304640, 2024 | | 2024 |
| Amorphous solid dispersion augments the bioavailability of phloretin and its therapeutic efficacy via targeting mTOR/SREBP-1c axis in NAFLD mice J Chhimwal, RK Dhritlahre, P Anand, V Patial, A Saneja, YS Padwad Biomaterials Advances 154, 213627, 2023 | | 2023 |
| Nano-delivery of Bioactive Constituents from Apple Pomace Ruchika, RK Dhritlahre, A Saneja Sustainable Agriculture Reviews 56: Bioconversion of Food and Agricultural …, 2022 | | 2022 |
